Special items: Ovarian Cancer and Us blog best viewed in Firefox

Wednesday, December 28, 2011

Incorporation of Bevacizumab (Avastin) in the Primary Treatment of Ovarian Cancer — NEJM

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer — NEJM

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.